ZDHHC3 and prostate neoplasm: ZDHHC3‐mediated palmitoylation plays a key role in regulating the expression, stability, and function of integrin α6β4, and knockdown of ZDHHC3 with shRNA affects integrin‐dependent cable formation and signaling in prostate tumor cells [124].